Cargando…

Antisense DNA and RNA Strategies: New Approaches to Therapy

This review describes the results both in vitro and in vivo of the application of small DNA molecules or their analogues to target sequences in messenger RNA (mRNA) or DNA. Biological effects on the replication of viruses and the expression of oncogenes are recorded. At the same time, RNA catalytic...

Descripción completa

Detalles Bibliográficos
Autor principal: Gibson, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of Physicians of London 1994
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401094/
https://www.ncbi.nlm.nih.gov/pubmed/7884705
_version_ 1783230970059554816
author Gibson, Ian
author_facet Gibson, Ian
author_sort Gibson, Ian
collection PubMed
description This review describes the results both in vitro and in vivo of the application of small DNA molecules or their analogues to target sequences in messenger RNA (mRNA) or DNA. Biological effects on the replication of viruses and the expression of oncogenes are recorded. At the same time, RNA catalytic sequences ('ribozymes') have been used to target and cleave mRNA sequences. Before these treatments can be confidently applied to clinical situations, further work is needed on their stability, cellular uptake and selection of their target, and the mechanism of their action also needs to be understood and controlled. In this way, it may be possible to guarantee specific effects on gene or cell type. The review describes the current research and state of development.
format Online
Article
Text
id pubmed-5401094
institution National Center for Biotechnology Information
language English
publishDate 1994
publisher Royal College of Physicians of London
record_format MEDLINE/PubMed
spelling pubmed-54010942019-01-22 Antisense DNA and RNA Strategies: New Approaches to Therapy Gibson, Ian J R Coll Physicians Lond Overviews This review describes the results both in vitro and in vivo of the application of small DNA molecules or their analogues to target sequences in messenger RNA (mRNA) or DNA. Biological effects on the replication of viruses and the expression of oncogenes are recorded. At the same time, RNA catalytic sequences ('ribozymes') have been used to target and cleave mRNA sequences. Before these treatments can be confidently applied to clinical situations, further work is needed on their stability, cellular uptake and selection of their target, and the mechanism of their action also needs to be understood and controlled. In this way, it may be possible to guarantee specific effects on gene or cell type. The review describes the current research and state of development. Royal College of Physicians of London 1994 /pmc/articles/PMC5401094/ /pubmed/7884705 Text en © Journal of the Royal College of Physicians of London 1994 http://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) , which permits non-commercial use and redistribution provided that the original author and source are credited.
spellingShingle Overviews
Gibson, Ian
Antisense DNA and RNA Strategies: New Approaches to Therapy
title Antisense DNA and RNA Strategies: New Approaches to Therapy
title_full Antisense DNA and RNA Strategies: New Approaches to Therapy
title_fullStr Antisense DNA and RNA Strategies: New Approaches to Therapy
title_full_unstemmed Antisense DNA and RNA Strategies: New Approaches to Therapy
title_short Antisense DNA and RNA Strategies: New Approaches to Therapy
title_sort antisense dna and rna strategies: new approaches to therapy
topic Overviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401094/
https://www.ncbi.nlm.nih.gov/pubmed/7884705
work_keys_str_mv AT gibsonian antisensednaandrnastrategiesnewapproachestotherapy